These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 28745142)

  • 21. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets.
    Ramassamy C
    Eur J Pharmacol; 2006 Sep; 545(1):51-64. PubMed ID: 16904103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effects of anthocyanins and their in vivo metabolites in SH-SY5Y cells.
    Tarozzi A; Morroni F; Hrelia S; Angeloni C; Marchesi A; Cantelli-Forti G; Hrelia P
    Neurosci Lett; 2007 Aug; 424(1):36-40. PubMed ID: 17709193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes.
    Esposito E; Rotilio D; Di Matteo V; Di Giulio C; Cacchio M; Algeri S
    Neurobiol Aging; 2002; 23(5):719-35. PubMed ID: 12392777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of neurotrophic signaling pathways by polyphenols.
    Moosavi F; Hosseini R; Saso L; Firuzi O
    Drug Des Devel Ther; 2016; 10():23-42. PubMed ID: 26730179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Inflammatory Activities of Marine Algae in Neurodegenerative Diseases.
    Barbalace MC; Malaguti M; Giusti L; Lucacchini A; Hrelia S; Angeloni C
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31234555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic promise of carotenoids as antioxidants and anti-inflammatory agents in neurodegenerative disorders.
    Kabir MT; Rahman MH; Shah M; Jamiruddin MR; Basak D; Al-Harrasi A; Bhatia S; Ashraf GM; Najda A; El-Kott AF; Mohamed HRH; Al-Malky HS; Germoush MO; Altyar AE; Alwafai EB; Ghaboura N; Abdel-Daim MM
    Biomed Pharmacother; 2022 Feb; 146():112610. PubMed ID: 35062074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Potential for Natural Antioxidant Supplementation in the Early Stages of Neurodegenerative Disorders.
    Oppedisano F; Maiuolo J; Gliozzi M; Musolino V; Carresi C; Nucera S; Scicchitano M; Scarano F; Bosco F; Macrì R; Ruga S; Zito MC; Palma E; Muscoli C; Mollace V
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease.
    Nakajima A; Ohizumi Y
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quercetin in hypoxia-induced oxidative stress: novel target for neuroprotection.
    Pandey AK; Patnaik R; Muresanu DF; Sharma A; Sharma HS
    Int Rev Neurobiol; 2012; 102():107-46. PubMed ID: 22748828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective Function of Different Antioxidant Containing Natural Products in the Treatment of Neurodegenerative Diseases.
    Rahman MH; Akter R; Kamal MA
    CNS Neurol Disord Drug Targets; 2021; 20(8):694-703. PubMed ID: 32703143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation.
    Ullah F; Liang A; Rangel A; Gyengesi E; Niedermayer G; Münch G
    Arch Toxicol; 2017 Apr; 91(4):1623-1634. PubMed ID: 28204864
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
    Maccioni RB; Muñoz JP; Barbeito L
    Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Nrf2-ARE Signalling pathway: promising drug target to combat oxidative stress in neurodegenerative disorders.
    van Muiswinkel FL; Kuiperij HB
    Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):267-81. PubMed ID: 15975029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ingredients for functional drinks in neurodegenerative diseases: a review.
    Zafrilla P; Morillas JM; Rubio-Perez JM; Cantos Villar E
    Nat Prod Commun; 2009 May; 4(5):719-40. PubMed ID: 19445320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease.
    Klegeris A; McGeer PL
    Curr Alzheimer Res; 2005 Jul; 2(3):355-65. PubMed ID: 15974901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Natural Compounds in Neurodegenerative Disorders.
    Srivastava P; Yadav RS
    Adv Neurobiol; 2016; 12():107-23. PubMed ID: 27651251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the Neuroprotective and Anti-Inflammatory Effects of the Anthocyanin Metabolites, Protocatechuic Acid and 4-Hydroxybenzoic Acid.
    Winter AN; Brenner MC; Punessen N; Snodgrass M; Byars C; Arora Y; Linseman DA
    Oxid Med Cell Longev; 2017; 2017():6297080. PubMed ID: 28740571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hydrophobic plant antioxidants. Preparation of nanoparticles and their application for prevention of neurodegenerative diseases. Review and experimental data.
    Muronetz V; Asryants R; Semenyuk P; Schmalhausen E; Saso L
    Curr Top Med Chem; 2014; 14(22):2520-8. PubMed ID: 25478884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.
    Paloczi J; Varga ZV; Hasko G; Pacher P
    Antioxid Redox Signal; 2018 Jul; 29(1):75-108. PubMed ID: 28497982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease.
    Ghosh N; Ghosh R; Mandal SC
    Free Radic Res; 2011 Aug; 45(8):888-905. PubMed ID: 21615270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.